In a new study, just published in the journal Annals of Family Medicine, researchers interviewed doctors about the barriers that prevent them from being able to decrease excess medications. Doctors called it “swimming against the tide,” citing patient expectations, the medical prescribing culture, and the structure of the medical business as factors making it difficult to deprescribe. This is particularly striking in light of the recent study that found that people who want to decrease their psychiatric medication found their mental health providers unhelpful.
“Adverse drug events and resultant hospital admissions are common in older people, costing health systems billions of dollars every year,” the researchers write. “Up to 10% of hospital admissions result from drug-related problems, two-thirds of which are considered preventable through safer prescribing.”
Particularly for older people, polypharmacy (taking multiple prescribed medications) may lead to dangerous drug interactions and side effects. The researchers write that careful prescription practices—including deprescribing—can help reduce these risks.
However, the authors write that “Despite evidence to guide safe prescribing, high-risk prescribing in older people is common, with 1 in 5 prescriptions potentially inappropriate.”
The researchers were led by Katharine Wallis, at the University of Auckland, New Zealand. They hoped to get an insider’s look into what barriers prevent doctors from feeling confident in deprescribing. As such, they interviewed 24 physicians from a variety of practice settings and years of experience.
According to the doctors interviewed, deprescribing was not rewarded by the medical profession. “The only incentive to deprescribing they identified was the duty to do what was right for the patient.” That is, these doctors effectively considered the safety and benefit of the patient to be at odds with the culture of prescribing enforced in the medical profession.
According to the researchers, doctors “said prescribing was the easy option, while deprescribing was time-consuming and came with inherent risks both for themselves and for patients. They said patients expected there to be ‘a pill for every ill’ and that this expectation was exacerbated by direct-to-consumer advertising of medicines in New Zealand.” The United States is the only other country that allows direct-to-consumer advertising of medications.
The authors also write that “Some physicians, especially the younger and less experienced ones, described a professional etiquette that left them reluctant to stop medicines initiated by others. They felt uncomfortable going against the prescribing of the patient’s usual doctor and of specialists, both of whom they felt knew better than they did.”
Some of the actual quotes from doctors interviewed by the researchers are quite telling about the culture of prescription:
Doctors also discussed the pressures of the medical system as barriers to deprescription:
The doctors also mentioned many ideas of how to make deprescription more accessible, including improvements to clinical practice guidelines, scheduled sessions to review medications with patients, better collaboration with patients, and improved training on how to deprescribe.
According to the researchers, the only current reason doctors consider deprescription is their individual judgment of what is best for their patients. The researchers, therefore, encourage policy and research improvements that will help support the primary goals of physicians—to help, rather than harm, their patients.
Wallis, K. A., Andrews, A., & Henderson, M. (2017). Swimming against the tide: Primary care physicians’ views on deprescribing in everyday practice. Annals of Family Medicine, 15(4), 341-346. doi: 10.1370/afm.2094